eFoodSafety.com, Inc., through its wholly owned subsidiary Cinnergen, Inc., has developed Cinnergen Healing Cream, a non-toxic topical cream to repair skin problems, including sores and dryness, for patients with blood sugar level imbalances. The cream can be used on a daily basis to help prevent and remedy these common skin conditions. The company plans to market the product in conjunction with its product CinnergenTM, a whole foods liquid supplement that promotes healthy glucose metabolism.

Cinnergen Healing Cream's composition includes nutritive lipids and peptides that provide several healing effects, including anti-inflammatory, anti-bacterial, anti-fungal, and anti-microbial, all of which help improve the rate of healing in dry and damaged skin. According to clinical studies testing the efficacy of its active compounds, the cream can help improve hydration, firmness, elasticity, smoothness, and other related qualities of the skin. The cream's lipid profile has historically been used topically to relieve nerve pain, and its components have also been shown to dramatically increase the rate of healing of skin sores and ulcers. The cream can also be used to repair rashes, sores, swelling, and abrasions.

An estimated one in three diabetics suffers from moderate to severe skin abrasions and dryness, often due to negative metabolic efficiency and poor circulation. For diabetics, and others with blood sugar imbalances and insulin resistance, increased sugar in the bloodstream can decrease circulation in small and medium blood vessels, thereby lessening the amount of oxygen and nutrients that can reach the outer layers of the skin. The result is often unhealthy or diseased skin and slow healing wounds, as well as neuralgia, a disorder of the nerves. Left untreated, these conditions can become quite painful and sometimes serious.

"Cinnergen Healing Cream is a great complement to our existing product Cinnergen, which helps promote healthy glucose metabolism," states Patricia Gruden, CEO of eFoodSafety. "The cream not only provides great relief for the many skin problems that commonly affect people with elevated blood sugar, but it also reflects eFoodSafety's concerted efforts of continuing to develop branded product lines and building a highly refined portfolio of health related offerings for persons with blood sugar imbalances and other medical conditions. We continue to strive for innovation and remain keenly focused on building long-term shareholder value."

About eFoodSafety.com

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin™ (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte™ product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company is the owner of Cinnergen™, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism available for sale at (http://www.cinnergen.com) and through national retailers; and Cinnechol™, a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

The company's iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar™, a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body's immune system. The product contains Citroxin™, eFoodSafety's proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar™ is available in three delicious flavors: chocolate, oatmeal-raisin, mint and peanut butter and can be purchased at www.immuneboost.com.

The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn™-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (http://www.talsyn.com), as well as seven (7) other products in the Talsyn™ line.

Please visit the company's website at: http://www.eFoodSafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects" and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.